Skip to main content
. 2021 Sep 10;11:18076. doi: 10.1038/s41598-021-97661-1

Table 1.

Demographic and clinical characteristics of subjects according to type of disease.

CD (n = 155) UC (n = 123) p
Gender [M, n (%)] 97 (62.6%) 57 (46.3%) 0.010a
Age [years, median (IQR)]) 15.2 (12.6; 16.7) 14.6 (12.5; 16.5) 0.258b
Disease duration [years, median (IQR)] 2.9 (1.4; 5.2) 3.8 (1.7; 6.2) 0.052b
Z-score weight [median (IQR)] − 0.5 (− 1.2; 0.3) − 0.4 (− 0.9; 0.2) 0.663b
Z-score BMI [median (IQR)] − 0.48 (− 1.1; 0.2) − 0.4 (− 1.19; 0.2) 0.795b
Disease activity
N. of relapses [median (IQR)] 0 (0; 3) 0 (0; 4) 0.012b
PUCAI/w-PCDAI [n (%)] 0.492c
Remission 111 (73.5%) 90 (75%)
Mild 33 (21.9%) 20 (16.7%)
Moderate 5 (3.3%) 7 (5.8%)
Severe 2 (1.3%) 3 (2.5%)
PGA [n (%)] 0.138c
Remission 106 (70.2%) 87 (75.5%)
Mild 37 (24.5%) 17 (14.8%)
Moderate 7 (4.6%) 9 (7.8%)
Severe 1 (0.7%)
Surgery [yes, n (%)] 9 (11.25%) 6 (8.45%) 0.439a
Fecal calprotectin > 250 ug/g [yes, n (%)] 32 (36.4%) 30 (44.1%) 0.800a
Fecal calprotectin [ug/g; median (IQR)] 118 (37; 427) 193 (32; 707) 0.364b

p-values refer to: aChi-square test; bWilcoxon test; cFisher Exact test.

IQR interquartile range.

HHS Vulnerability Disclosure